Intervention

Trastuzumab 8 mg/kg iv saturation, then 6 mg/kg iv (HER2 positive patients only)

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast CancerNCT02909751 · 2016-09-14

COMPLETED

Common conditions

Breast Cancer1

Leading sponsors

Vejle Hospital1

Trial status mix

COMPLETED1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.